MIRM
Mirum Pharmaceuticals Inc
NASDAQ: MIRM · HEALTHCARE · BIOTECHNOLOGY
$94.20
+0.21% today
Updated 2026-04-29
Market cap
$5.74B
P/E ratio
—
P/S ratio
11.02x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$40 – $109
Volume
0.8M
Mirum Pharmaceuticals Inc (MIRM) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $51.98M | $146.71M | $240.86M | $294.65M | $352.91M | $646.62M | $670.75M |
| Cash & equivalents | — | — | — | — | — | — | — |
| Current assets | $51.98M | $119.36M | $236.35M | $166.59M | $190.22M | $387.54M | $392.79M |
| Total liabilities | $62.30M | $16.36M | $68.77M | $174.44M | $210.87M | $397.95M | $445.11M |
| Current liabilities | $2.45M | $13.08M | $18.46M | $42.60M | $64.73M | $87.06M | $126.55M |
| Long-term debt | $0.00 | — | — | — | — | $306.42M | $308.08M |
| Shareholder equity | — | — | — | — | — | — | — |
| Retained earnings | $-17.35M | $-69.90M | $-173.17M | $-257.16M | $-392.82M | $-556.24M | $-644.18M |
| Accounts receivable | — | — | $0.00 | $3.27M | $23.99M | $67.97M | $78.29M |
| Inventory | $0.00 | — | $0.00 | $1.51M | $5.57M | $22.31M | $22.40M |
| Goodwill | $0.00 | — | — | — | — | — | — |